Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $11.8 million.

  • Lexeo Therapeutics' Accumulated Expenses changed N/A to $11.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $11.8 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Lexeo Therapeutics' Accumulated Expenses stood at $11.8 million.
  • Lexeo Therapeutics' 5-year Accumulated Expenses high stood at $11.8 million for Q3 2023, and its period low was $6.4 million during Q4 2022.